With regard to triple-negative breast cancer (TNBC), the transcript levels of HTR1D/2C/6 were increased, HTR1F/2A/2B/4 expressions were decreased, and HTR1E/3A/3C/7 levels were unchanged (Figure 2B). This evidence concerns the gene HTR1D and triple-negative breast carcinoma.